ABBV

8
Abbvie
Stock :NYSE
: Healthcare
: Drug Manufacturers—General
Miracle Viewer
  27/05/2022 21:00 GMT+2
0.99
157.57266
106.02152
0.629
-0.053
-0.058

Ruota il tuo smartphone per vedere un grafico migliore
Ruota il tuo smartphone per vedere un grafico migliore

Operativity type

LONG
Profit %
96.08 %
Timeframe
H 24
Duration
48
ABBV
Sector: Health Technology
Industry: Pharmaceuticals: Major
Employees: 47000

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products.

It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.